Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 45 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

18%

8 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

18 recruiting1 with results

Enrollment Performance

Analytics

N/A
17(48.6%)
Phase 2
10(28.6%)
Phase 3
6(17.1%)
Phase 4
2(5.7%)
35Total
N/A(17)
Phase 2(10)
Phase 3(6)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (45)

Showing 20 of 45 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT05738642Not ApplicableCompleted

Efficacy and Safety of Early Use PCC in Severe Trauma

Role: collaborator

NCT06968936Not ApplicableRecruiting

Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy

Role: collaborator

NCT07518810Phase 2Not Yet Recruiting

Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy

Role: collaborator

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT06850103Phase 2Recruiting

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Role: collaborator

NCT06977516Completed

Atrial Fibrillation Recurrence Prediction

Role: collaborator

NCT07413809Phase 3Recruiting

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Role: collaborator

NCT07177586Not ApplicableRecruiting

New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway

Role: collaborator

NCT07359014Not ApplicableRecruiting

Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma

Role: collaborator

NCT07347977Not ApplicableNot Yet Recruiting

Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk

Role: collaborator

NCT06596005Phase 2Completed

Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

Role: collaborator

NCT04320979Phase 3Active Not Recruiting

Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients

Role: collaborator

NCT06520163Phase 3Recruiting

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT07127809Not ApplicableCompleted

Mindfulness-Based Intervention Targeting Psychological Capital to Reduce Job Burnout Among Nurses

Role: collaborator

NCT03957707Not ApplicableActive Not Recruiting

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation

Role: collaborator

NCT04694248Not ApplicableRecruiting

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Role: collaborator

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT07035808Phase 2Not Yet Recruiting

a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer .

Role: collaborator